Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB)

CUSIP: 23285D109

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock - $0.001 par value
Shares outstanding
127,940,509
Total 13F shares
77,486,686
Share change
+450,632
Total reported value
$427,726,918
Put/Call ratio
29%
Price per share
$5.52
Number of holders
106
Value change
-$3,527,385
Number of buys
73
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 23285D109?
CUSIP 23285D109 identifies CTKB - Cytek Biosciences, Inc. - Common Stock - $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB) as of Q3 2023

As of 30 Sep 2023, Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB) was held by 106 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 77,486,686 shares. The largest 10 holders included BlackRock Inc., BROWN CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NEW YORK STATE COMMON RETIREMENT FUND, WELLINGTON MANAGEMENT GROUP LLP, and NORTHERN TRUST CORP. This page lists 106 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.